ArticleClinical and translational science2022

Liquid biopsy-based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer.

Seta Derderian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.